Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Infection and Immunity|July 15, 2015
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsRaul Herrera, Charles Anderson, Krishan Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US AdultsSara A Healy, Sean C Murphy, Jen C C Hume, et al.
The Lancet. Infectious Diseases|August 1, 2018
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adultsIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2024
Analytical Sensitivity Analysis and Clinical Impact Modeling of Rapigen Rapid Diagnostic Tests for MalariaAllison Golden, Hannah C Slater, Ihn Kyung Jang, et al.
The American Journal of Tropical Medicine and Hygiene|March 26, 2024
Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural MaliM'Bouye Doucoure, Amatigue Zeguime, Amadou Niangaly, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
NEJM Evidence|June 24, 2025
A Vaccine to Block Plasmodium falciparum TransmissionSara A Healy, Issaka Sagara, Mahamadoun H Assadou, et al.
The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Nature Communications|March 20, 2021
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametesCamila H Coelho, Wai Kwan Tang, Martin Burkhardt, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Pageof 24